Sanofi Competitors and Similar CompaniesClear all
Viatris's competitors and similar companies include Lilly, Novartis and Teva Pharmaceuticals.
 Viatris Viatris is a pharmaceutical company that develops and manufactures branded and generic medicines, biosimilar medicines, and over-the-counter products. |  Lilly Eli Lilly is a company that discovers, develops, manufactures, and markets pharmaceutical products. |  Novartis Novartis is a company that researches, develops, manufactures, and markets healthcare products. | ||
Founding Date | Founding Date 2020 | Founding Date 1876 | Founding Date 1996 | Founding Date 1901 |
Type | Type Public | Type Public | Type Public | Type Public |
Tags | ||||
Locations | Locations Canonsburg, US HQ Carole Park, AU Millers Point, AU Campos Dos Goytacazes, BR São Paulo, BR Sofia, BG Toronto, CA see more | Locations Indianapolis, US HQ Buenos Aires, AR Sydney, AU Wien, AT Brussel, BE São Paulo, BR Toronto, CA see more | Locations Basel, CH HQ Tirana, AL Buenos Aires, AR Macquarie Park, AU Kundl, AT Unterlangkampfen, AT Wien, AT see more | Locations Petah Tikva, IL HQ Villa Adelina, AR Macquarie Park, AU Minsk, BY Antwerpen, BE Sao Paulo, BR Dupnica, BG see more |
Employees | Employees 38,0003% increase | Employees 47,0009% increase | Employees 75,883 | Employees 37,000 |
Valuation ($) | Valuation ($) 14 b | Valuation ($) 903.4 b | Valuation ($) N/A | Valuation ($) 20.8 b |
Financial | ||||
Revenue (est.) | Revenue (est.) $14.3b (FY, 2025) | Revenue (est.) $65.2b (FY, 2025) | Revenue (est.) $56.7b (FY, 2025) | Revenue (est.) $17.3b (FY, 2025) |
Cost of goods | Cost of goods $9.3b (FY, 2025) | Cost of goods $11.1b (FY, 2025) | Cost of goods $8.4b (FY, 2025) | Cost of goods $8.3b (FY, 2025) |
Gross profit | Gross profit $5b (FY, 2025) | Gross profit $54.1b (FY, 2025) | Gross profit $49.8b (FY, 2025) | Gross profit $8.9b (FY, 2025) |
Net income | Net income ($3.5b) (FY, 2025) | Net income $20.6b (FY, 2025) | Net income $14b (FY, 2025) | Net income $1.4b (FY, 2025) |
Operating ⚠ | ||||
Countries | Countries 165 (Q1, 2023) | Countries 120 (FY, 2021) | Countries N/A | Countries N/A |
Phase III Trials Products | Phase III Trials Products N/A | Phase III Trials Products 10 (FY, 2021) | Phase III Trials Products 44 (FY, 2022) | Phase III Trials Products N/A |
Funding | ||||
Total funding raised | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 6.5m | Total funding raised $ 358m |
For sources of this data, please see the company profile
View Company Profiles
Lilly
HQ
Indianapolis, US
Employees
47,000↑ 9% increase
Eli Lilly is a company that discovers, develops, manufactures, and markets pharmaceutical products.
View companyNovartis
HQ
Basel, CH
Employees
75,883
Novartis is a company that researches, develops, manufactures, and markets healthcare products.
View company
Teva Pharmaceuticals
HQ
Petah Tikva, IL
Employees
37,000
Teva Pharmaceuticals is a global pharmaceutical company.
View company